Aether Industries Limited has announced the allotment of 13,948 equity shares under its Employee Stock Option Scheme (ESOS) 2021, as approved by the Nomination and Remuneration Committee. This latest employee ownership initiative demonstrates the company's continued commitment to aligning employee interests with corporate growth objectives.

Latest Allotment Details

The company's regulatory filing reveals the specifics of this share allotment:

Updated Share Capital Structure

Following this allotment, Aether Industries' share capital structure has been updated:

The newly issued shares will rank pari-passu with existing equity shares, providing equal rights and privileges to the beneficiaries.

ESOS 2021 Framework

Aether Industries' Employee Stock Option Scheme 2021 operates under regulatory approvals from major stock exchanges. The scheme has received in-principle approval for a total pool of 11,00,000 equity shares from both BSE Limited and National Stock Exchange of India Limited.

Regulatory Compliance and Next Steps

The company has fulfilled all regulatory requirements for this allotment. Aether Industries will communicate this corporate action to depositories for crediting shares to beneficiaries' accounts, followed by obtaining listing and trading approvals from stock exchanges. The company has already paid listing fees for issued share capital up to Rs. 200 crores for the current fiscal year, requiring no additional exchange fees.

Strategic Implications

This employee stock option allotment reinforces Aether Industries' strategy of enhancing employee engagement and retention in the competitive specialty chemicals sector. By providing equity participation opportunities, the company aims to strengthen its human capital foundation while fostering long-term employee commitment to organizational success.

Aether Industries Limited, a specialty chemicals manufacturer, has reported a strong financial performance for the second quarter of fiscal year 2026, with significant revenue growth and improved profitability. The company also announced plans for expansion of its research and development capabilities.

Financial Highlights

Aether Industries achieved consolidated revenue of Rs. 275.10 crores in Q2 FY26, representing a 38% increase from Rs. 198.80 crores in Q2 FY25. The company's EBITDA margins improved to 31% from 25% in the same period last year.

Business Segment Performance

The company's sales mix for the quarter was distributed across its three business verticals:

• Contract and Exclusive Manufacturing: 47%
• Large-scale Manufacturing: 41%
• Contract Research and Manufacturing Services (CRAMS): 9%

Notably, the Contract and Exclusive Manufacturing segment contributed more than the Large-scale Manufacturing business for the first time, aligning with the company's vision to have CRAMS and Contract Manufacturing contribute 60-70% of sales in the next two years.

R&D Expansion

Aether Industries is expanding its R&D capacity:

• Adding 24 new fume hoods in the existing facility
• Planning a new R&D extension with over 130 fume hoods
• Introducing engineering labs focusing on chemical engineering and technology scale-up

Dr. Aman Desai, Promoter & Whole-Time Director, emphasized the importance of these expansions, particularly in targeting petrochemical, oil and gas, and material science sectors.

Production Capacity Expansion

The company plans to commission three new production blocks:

• Site-3+: Dedicated to Milliken, expected to commence production in Q4 FY26
• Site-5 (Panoli): Two production blocks of Phase-1 targeted for commissioning by early Q4 FY26

Future Outlook

Aether Industries expects to maintain its growth momentum, projecting around 25% growth going forward. The company aims to sustain EBITDA margins of approximately 30%.

Investor Relations

The company participated in the 'Avendus Spark INDX' event in Mumbai, meeting with various investors and discussing publicly available information. This engagement demonstrates Aether Industries' commitment to transparency and investor communication.

As Aether Industries continues to expand its R&D capabilities and production capacity, it aims to capitalize on the growing opportunities in the specialty chemicals sector, particularly in non-pharmaceutical and non-agrochemical segments.